Novo's CagriSema helped women lose 25% of weight on average, analysis shows

Novo said a 2.4 milligram dose of CagriSema was associated with an average weight loss of 25% after 68 weeks in 2,309 women enrolled in a late-stage study called REDEFINE 1,…

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (live.euronext.com)